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The cloning of the cDNA for the a1 subunit of L-type calcium channels revealed that at least two genes 
(CaChl and CaCh2) exist which give rise to several splice variants. The expression of mRNA for these a1 subunits 
and the skeletal muscle a2/6, p and y subunits was studied in rabbit tissues and BC3Hl cells. Nucleic-acid- 
hybridization studies showed that the mRNA of all subunits are expressed in skeletal muscle, brain, heart and 
aorta. However, the al-, p- and y-specific transcripts had different sizes in these tissues. Smooth muscle and heart 
contain different splice variants of the CaCh2 gene. The a l ,  /? and y mRNA are expressed together in differentiated 
but not in proliferating BC3H1 cells. A probe specific for the skeletal muscle a2/6 subunit did not hybridize to 
poly(A)-rich RNA from BC3Hl cells. These results suggest that different splice variants of the genes for the a l ,  
jl and y subunits exist in tissues containing L-type calcium channels, and that their expression is regulated in a 
coordinate manner. 
Voltage-activated calcium channels comprise a group of 
very similar yet distinct proteins or protein complexes that 
differ in electrophysiological properties, modulation by phos- 
phorylation and guanosine-nucleotide-binding regulatory 
proteins, and in their relative sensitivity to organic-calcium- 
channel blockers [l - 41. The principal transmembrane subunit 
of an L-type calcium channel is the receptor for calcium chan- 
nel blockers or a1 subunit, and when purified from rabbit 
skeletal muscle this protein (165 kDa) is associated with a 55- 
kDa protein (j?), a 32-kDa protein (y) and a disulfide-linked 
dimer of 130/28 kDa (a2/8) [5-81. The primary structures of 
the a1 [9- 1 I], a J 6  [lo, 121, p [I31 and y proteins [14, 151 have 
been deduced by cloning their cDNA and al-like proteins 
have been identified in a variety of tissues from different 
species on the basis of sequence homology with their skeletal 
muscle counterpart [I6 - 231. 
However, only the expression of full-length cDNA of the 
a1 subunits from rabbit heart [I61 and lung [I71 in Xenopus 
laevis oocytes results in dihydropyridine-sensitive calcium 
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channels. The transient expression of the skeletal muscle a1 
subunit in myoblasts from dysgenic mice [24] is complicated 
by the presence of endogenous Ca2 + currents. Its expression 
in murine L-cells [Il l  leads to the appearance of a di- 
hydropyridine-sensitive Ca2 + current, which activates about 
ten times slower than CaZf currents in skeletal muscle, and 
phenotypic cell lines of skeletal muscle, such as BC3H1 cells. 
The a2/6 and fl  subunits are missing in murine L-cells [25] and 
it has been suggested that to acquire skeletal muscle properties, 
a1 must be associated with one or more of the other subunits. 
In this case a common regulatory mechanism controlling the 
expression of calcium channel a1 subunits and other a2/6-, 8- 
and y-like proteins might exist, and mRNA for all subunits 
should be present in cells containing functional L-type calcium 
channels. Therefore, in this investigation, the expression of 
al, a2/6, p and y mRNA was studied in parallel by blot hy- 
bridization analysis using poly(A)-rich RNA from various 
rabbit tissues and BC3Hl cells, as well as subunit-specific 
RNA probes. It is shown that splice variants of the genes for 
these subunits are expressed in each tissue, and that in BC3H1 
cells only expression of the a l ,  p and y mRNA, but not of az/ 
6 mRNA, is regulated in a coordinate manner. 
MATERIALS AND METHODS 
Materials 
35S-labeled deoxyadenosine [a-thioltriphosphate [35S]- 
dATP (1.370 Ci/mmol), [c~-~ 'P]~CTP (3.000 Ci/mmol), [a- 
32P]GTP (800 Ci/mmol), (+)-isopropyl-4-(2,1,3-benzoxa- 
diazol-4-y1)- 1 ,4-dihydro-2,6-dimethyl-5-[3H]methoxycarbo- 
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Table 1. Recombinant antisense constructs 
Soure Plasmid Subunit Antisense probe Refer- 
positions ence 
Skeletal pCaAla al 1006-5314 9 
muscle pCA2a a2/6 2550 - 3528 16 
pCaBla /3 - 22 - 1608 13 
pCaGla y -48- 680 14 
Lung pCaCa al 2199-4335 17 
pATL a1 -118- 32 17 
Heart PATH a1 -191- 134 16 
nylpyridine-3-carboxylate ( +)[3H]PN200- 110, 85.9 Ci/ 
mmol] were purchased from DuPont-New England Nuclear. 
CsCl was from Gibco BRL Life Technologies. All enzymes 
were from Boehringer-Mannheim except Sequenase IITM and 
Taq polymerase which were from United States Biochemical 
GmbH and Perkin-Elmer GmbH, respectively. Guanidine 
isothiocyanate was from Fluka Chemie AG, salmon sperm 
DNA, polyvinylpyrrolidone and Ficoll were from Sigma 
Chemicals. Seakein GTG-agarose was from FMC Bioprod- 
ucts. Bacto-agar, yeast extract and bacto-tryptone were from 
Difco. Glass-fiber filters GFjC were obtained from Whatman. 
All other chemicals were of the highest quality available. 
Methods 
RNA-blot-hybridization analysis. For the preparation of 
antisense RNA probes, seven recombinant plasmids were con- 
structed carrying the SP6 promotor [26] and the nucleotide 
sequences of calcium channel subunits from skeletal muscle, 
lung and heart (Table 1). The skeletal muscle and lung se- 
quences were obtained by subcloning the respective cDNA [9, 
13, 14, 16, 171. The full-length cardiac c ( ~  cDNA was cloned 
using the nucleotide sequence of Mikami et al. [16]. Briefly, 
the XhoI - SphI fragment (the XhoI site is located in the oligo- 
deoxynucleotide linker 5’-CCGCTCGAGGTCGAC - 3’ at- 
tached to position - 191 ; the fragment runs to position 1488) 
and the BspHI - SacII (positions 3553 - 41 16) fragment of the 
cardiac a1 cDNA [I61 obtained by polymerase chain reaction 
(PCR) amplification of a random-primed cDNA library from 
rabbit heart and the SphI - BspHI (positions 1473 - 3542) 
fragment from pSCaL [17] were ligated with the 5.3-kb Xhol - 
SacII fragment from pSCaL [17] to yield the pSP72 re- 
combinant plasmid pCaH. As in [16], the cloned cardiac 
cDNA induces the formation of a high-voltage-activated 
dihydropyridine-sensitive L-type calcium channel when ex- 
pressed in Xenopus oocytes. The antisense RNA probes were 
synthesized in vitro with [LX-~’P]GTP using the linearized 
plasmids as templates for transcription with SP6 polymerase. 
RNA-blotting analysis was carried out essentially according 
to [27] except that Biodyne nylon membranes (Pall) were used 
and that hybridization was performed at 65°C in the presence 
of 50% formamide and 0.5% SDS. For blot-hybridization 
analysis, total RNA was prepared from tissues of adult rabbits 
or from BC3H1 cells by the guanidinium thiocyanate method 
and poly(A)-rich RNA, as in [13, 141. The yield of poly(A)- 
rich RNA during oligo(dT)-cellulose chromatography was 
5 - 7% for all preparations. 
Cell culture 
BC3H1 (ATCC 1443) cultures were grown in Dulbecco’s 
modified Eagle’s medium containing 20% fetal bovine serum, 
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Fig. 1. Autoradiograms of blot hybridization analysis ofpoly(A)-rich 
RNA f rom adult rabbit tissues. Samples of 10 pg poly(A)-rich RNA 
from skeletal muscle (lane 1). brain (lane 2), heart (lane 3), aorta (lane 
4), trachea (lane 5 )  and lung (lane 6) were electrophoresed on 1.2% 
agarose gels. Autoradiographic exposure was 16 h (a, lanes 2, 5 and 
6; d, lanes 1-3; b and f ) ,  3 days (a, lanes 1, 3 and 4; d, lanes 4-6; 
e) and 20 days (c). The size markers used were Escherichia coli rRNA 
and the RNA ladder purchased from Gibco BRL Life Technologies. 
The RNA probes used were specific for the a1 subunits from heart 
and lung (a), heart (b), lung (c) and for the skeletal muscle a,/S (d), 
(e) and y (0 subunits. The specific activities of the six probes used 
were 0.8 - 2.2 x lo9 dpm/pg 
penicillin (100 U/ml) and streptomycin (100 pg/ml), as de- 
scribed in [28]. The medium was changed every 2 days. To 
minimize differentiation, BC3H1 cells were passaged when no 
more than 60% confluent. P1-, P2-, and P3-designate pro- 
liferating BC3H1 cells were used which were 10-20%, 30- 
50% and 60 - 80% confluent, respectively. Differentiation 
was induced by reduction of the fetal bovine serum concen- 
tration to 0.5%. For binding assays and RNA preparation, 
cells were washed twice with Hanks’ balanced salt solution, 
collected by scraping, sedimented and frozen at - 80°C. 
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Table 2. CaCI~ZA-deri~wl [ 161 and CuChZB-derived [ I  71 oligodeoxynucleotide primers used for cDNA synthesis and PCR 
Primer Sequence Subunit Positions 
1 5’- GTGTTCAGGAAGACCAG- 3’ CaCh2B 1672to 1688 
CaCh2B 186to 203 
CaCh2B 1442to 1461 
2 5’-TAAAACGTAAAGTATTACTAAAACCTC-3’ CaCh2A -191 to -165 
3 5’-GCACTGCCCATCAGCTTG- 3’ 
4 5’-TGCGCCGCCTCGCTCTGTT-3’ CaCh2B -312 to -294 
6 5’-CATGGGTCTCTGTGGAGTGACTAA3’ 
[3H]PN200- 110 binding to BC3Hl cells 
Cell pellets were thawed in 5mM Tris/HCl, pH 7.4contain- 
ing 0.1 mM phenylmethylsulfonyl fluoride, 1 mM phenan- 
throline, 100 mM iodoacetamide, 1 mM benzamidine, lpM 
pepstatin A, 1 pg/ml antipain and 1 pg/ml leupeptin (protease 
inhibitor mix), homogenized and centrifuged at 1 0OOxg for 
20 min. The supernatant was then centrifuged at 42000x1: for 
40 min at 4 ’C. The pellet was rehomogenized in 50 mM Tris/ 
HC1, pH 7.4 containing the protease inhibitor mix. Equilib- 
rium binding of (+)[‘HH]PN200- 110 was performed as de- 
scribed previously [29] in the presence of 25 pg protein and 
1 nM ( +)[’H]PN200- 110 at 22‘C for 45 min. Nonspecific 
binding was determined in the presence of 2 pM unlabelled 
PN200 - 11 0. 
Miscvllaneous methods 
Oligodeoxynucleotide synthesis was run by standard pro- 
tocol supplied by the manufacturer on an automated single- 
column synthesizer. PCR were performed as in [14] and the 
amplificd cDNA were subcloned and sequenced on both 
strands [30]. Cloning procedures, if not stated otherwise, were 
carried out as described [3 I]. Protein concentrations were 
determined according to [32]. 
RESULTS 
Tissue specific expression of calcium channel subunits 
The tissue-specific distribution of mRNA specific for the 
calcium channel txl, a 2 / 6 ,  j’l and y subunits was analyzed by 
RNA-blot analysis of poly(A)-rich RNA from several rabbit 
tissues using subunit-specific antisense RNA probes. In 
Fig. 1 a, a probe derived from domains 3 and 4 of CaCh2 
hybridized to a poly(A)-rich RNA species in skeletal muscle 
of 6.5 kb, which is identical to the skeletal muscle al subunit 
mRNA described previously [9 - 1 I]. A less-abundant mRNA 
species, with an estimated size of about 8.9 kb, is also present 
in skeletal muscle. In contrast, 8.9-kb, but not 6.5-kb, tran- 
scripts were detected in poly(A)-rich RNA from brain, heart, 
aorta, trachea and lung. In addition, weakly hybridizing tran- 
scripts of about 35.5 kb were observed in these tissues. The 
intensity of the txl hybridization signals varied among the 
different tissues, being most intense in skeletal muscle and 
lung. 
To investigate the expression of transcripts related to those 
encoding the lung and cardiac muscle a1 subunits, specific 
RNA probes derived from their S’nucleotide sequences were 
used (Fig. 1 b and c). For the cardiac-channel-specific probe, 
aproininent 8.9-kb and amuch weaker 15.5-kb transcript were 
detected in poly(A)-rich RNA from cardiac muscle (Fig. 1 b). 
However, no signals were detected in other tissues, even after 
two weeks autoradiographic exposure (data not shown). The 
probe derived from the lung a1 sequence hybridized to a 
number of RNA species in all tissues, including 8.9-kb and 
15.5-kb transcripts in brain, heart, aorta, trachea and lung 
(Fig. 1 c). 
The probe of the skeletal n2/6 subunit hybridized to an 
8.0-kb transcript in poly(A)-rich RNA from each of the tissues 
examined (Fig. Id). In addition, a weakly hybridizing a2 
7.0-kb transcript was observed in these tissues. The 13-subunit- 
derived probe hybridized to three poly(A)-rich RNA species 
of skeletal muscle with estimated sizes of 1.6, 1.9 and 3.0 kb. 
mRNA species of similar size to the 3.0-kb species appear 
to be present in brain and aorta. A less-abundant mRNA 
population of about 4.8 kb, which was detected only as a faint 
band after long autoradiographic exposure, is present in heart. 
The y-subunit probe hybridized to a 1.3-kb poly(A)-rich RNA 
species from skeletal muscle [14, 151. Weakly hybridizing y 
transcripts of 1.0 kb (heart), and 1.3 kb and 1.8 kb (aorta) 
were observed. In brain, a 1.5-kb signal was clearly visible 
after 5 day autoradiographic exposure, but not after 16 h 
(compare Fig. 3B, d, lane 6, with Fig.1 f, lane 2). No txl-, ccz /  
6-, B- and y-specific hybridization was observed with poly(A)- 
rich RNA and total RNA from HeLa cells, murine L-cells 
and Paramecium tetraurelia. 
Characterization of tissue specfic expression of al subunits 
by PCR. The Northern-blot experiments indicated that 
CaCh2A is expressed only in heart, whereas CaCh2B seems 
to be expressed in heart, brain, aorta, lung and trachea (Fig. 1 b 
and c). To confirm the existence and differential expression of 
mRNA for type CaCh2A and CaCh2B by an independent 
method, CaCh2A- and CaCh2B-specific sequences were 
amplified by two sets of PCR from heart, lung and trachea. 
This method has an important advantage over Northern-blot 
analysis of RNA in that the exact sequence expressed in a 
given tissue can be determined. The general location of the 
sequence spanned by the primers used (Table 2) is depicted as 
a, b and c in Fig. 2A. These regions of the CaCh2 gene have 
been described as alternative splicing products [17]. Template 
cDNA were constructed with poly(A)-rich RNA from rabbit 
heart, lung and trachea using oligodeoxynucleotide primer 1 
which covers a region which is conserved between the cardiac 
(CaCh2A) and lung (CaCh2B) isoforms. For PCR covering 
the amino-terminal region (site a) pairs of oligonucleotides 
were used, which were derived from the 5’ sequence of 
CaCh2A (primer 2 )  and CaCh2B (primer 4) and a region 
which is identical in both isoforms (primer 3). Clones ampli- 
fied from cardiac cDNA with primers 2 and 3 had an identical 
sequence to that obtained by Mikami et al [16]. For example, 
the DNA sequence of rabbit clone 7 is 100% identical to that 
of the rabbit cardiac calcium channel (CaCh2A, Fig. 2B). 
However, using the same primer pair, but with cDNA from 
lung and trachea, did not lead to any specific amplification. 
In contrast, PCR initiated by primers 4 and 3 with cDNA from 
heart, lung and trachea yield specific amplification products in 
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CaCh2A : .................... M 
CaCh2B : GLHAQKKGKFAWFSHSTETHV 
cl 22 : GLHAQKKGKFAWFSHSTETHV 
cl 2 : GLHAQKKGKFAWFSHSTETHV 
cl 13 : GLHAQKKGKFAWFSHSTETHV 
IEY --- , identity .... gap 
Fig. 2. Diagram ofpart of the general structure of L-type calcium channels ( A )  and amino acid sequences of PCR products ( B , C )  obtained f rom 
firsl-strand cDNA derivedfrom rabbit heart, lung and trachea. (A) A representation of part of the a1 subunit of L-type calcium channels 
showing relative positions of the transmembrane segments (S) 1-6 of domain I. The hatched box represents the protein coding-region. 
Triangles indicate relative positions of oligodeoxynucleotide primers 1 -6 used for primer extension (1) and PCR (2-6). a-c Target sequences 
which are not identical in the a1 subunit cDNA cloned from rabbit heart [16] and lung 1171. (B, C) Results of PCR using specific primers 
derived from CaCh2A (2, 3) and CaCh2B (3 -6). The deduced amino acid sequences are compared with that of the rabbit cardiac muscle 
isoform (CaCh2A) 
method revealed that the clone amplified from cardiac cDNA 
(rabbit cardiac clone 41) is identical to the sequence of 
CaCh2B, except that it lacks 42 bp within the sequence con- 
served in CaCh2A and CaCh2B. The sequences of the clones 
obtained with cDNA from lung (clone 205) and trachea (clone 
67) were 100% identical to that of CaCh2B. 
For PCR covering sites b and c, pairs of oligonucleotide 
primers were derived from the 5' and 3' ends of sites b and c, 
respectively, of the CaCh2B sequence. DNA were amplified 
from heart, lung and trachea. Sequences of clones obtained 
from heart (rabbit cardiac clone 22), lung (clone 2) and trachea 
(clone 13) were 100% identical to that of CaCh2B (Fig. 2C). 
Expression of calcium channel transcripts in BC3H1 cells. 
The results of the nucleic acid hybridization studies indicated 
that mRNA of various al, a2/6, /3 and y subunits are coex- 
pressed in each tissue, suggesting that all subunits may con- 
8 5  
tribute to calcium channel function. In this case, their mRNA 
expression should be regulated in a coordinate manner. A 
model system to study this regulation is the clonal BC3H1 cell 
line. It is derived from a mouse brain tumor and possesses 
many properties characteristic of muscle [28]. In addition, 
differentiated, but not proliferating, BCJHl cells express volt- 
age-activated dihydropyridine-sensitive and dihydropyridine- 
insensitive calcium currents, whose electrophysiological 
properties are different from those found in smooth muscle, 
cardiac muscle and neurons and resemble best those found 
in skeletal muscle cells [33 - 351. Accordingly, differentiated 
BC3H1 cells express calcium-channel-blocker-binding sites 
(Fig. 3A, lane D), whereas these sites are barely detectable in 
subconfluent, proliferating cells (P1 - P3). To determine the 
expression of the mRNA of the calcium channel proteins, total 
RNA and poly(A)-rich RNA was isolated from proliferating 
subconfluent and differentiated BC3H1 cells. As shown in 
Fig. 3 B, a, a1 transcripts were barely detectable in pro- 
liferating cells (Fig. 3 B, a, lanes 2 - 4). However, after 
switching subconfluent BC3H1 cells to serum-deprived me- 
dium there was a marked induction of a 6.5-kb transcript 
(Fig. 3 B, a, lane 5) .  This a1 specific transcript was also induced 
when cells in growth medium reached confluence (data not 
shown). The size of this transcript is identical to that of the 
skeletal muscle a l  subunit (Fig. 3B,a, lane I), but different to 
various transcripts observed in rabbit brain (Fig. 3 B,a, 
lane6). In addition, a 4.0-kb transcript was observed in 
BC3H1 cells, which has been described previously [35] and 
has been attributed to nonspecific hybridization to the leading 
edge of 28s ribosomal RNA. For the j3 subunit, a 1.9-kb 
transcript was detected in total RNA from differentiated, but 
not from proliferating, cells (Fig. 3B,b, lane 5), whereas no 
a2/fi-specific transcripts were detectable (Fig. 3 B,c, lanes 2- 
5).  In contrast, a transcript specific for the y subunit was 
detected in total RNA from each of the cells examined 
(Fig. 3B,d, lanes 2-5). The intensity of this signal increase 
being most prominent in differentiated cells. Its size is similar 
to that of they transcript in skeletal muscle (Fig. 3 B, d, lane l), 
but smaller than that in brain (Fig. 3B,d, lane 6). Taken 
together, these results demonstrate, that a l ,  j3 and y mRNA 
are expressed together in differentiated but not in proliferating 
BC3H1 cells, suggesting that expression of their mRNA, but 
not of a2/d mRNA, is regulated in a coordinate manner. 
DISCUSSION 
In this investigation, the expression of the calcium channel 
al, a2/6, p and y mRNA was studied in various rabbit tissues 
and BC3H1 cells by Northern-blot analysis and PCR. It is 
shown that al-, a2/6-,  j3- and y-specific transcripts exist 
together in skeletal muscle, brain, heart and aorta, (b) that 
alternate splicing products for the CaCh2 gene are tissue- 
specifically expressed and (c) that in BC3H1 cells induction of 
a functional receptor for calcium channel blockers parallels 
the expression of al- ,  j3- and y-specific mRNA, suggesting that 
their expression is developmentally regulated. At least three 
a1 specific transcripts exist with estimated sizes of about 6.5, 
8.9 and 15.5 kb. The 6.5-kb transcript represents the mRNA 
of the skeletal muscle calcium channel a1 subunit [9 - 111. In 
the nomenclature used here, this transcript is derived from 
gene 1 (CaChl) and predominantly expressed in skeletal 
muscle (Fig Z a, lane l), although expression in other tissues 
has been described [lo, 181. The size of the second transcript 
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Fig. 3. Induction of dihydropyridine binding sites ( A )  und calcium 
channel subunits inRNAs ( B ) .  (A) Development of ['H]PN200-110- 
binding site density in proliferating (P1 -P3) and differentiated (D) 
BC3Hl cells. Open and hatched columns represent total and 
nonspecific binding, respectively. Bars indicate mean SEM from 
six different experiments performed in triplicate. (B) Samples of 2 pg 
poly(A)-rich RNA from rabbit skeletal muscle (lane 1)  and brain (lane 
6), 5 pg of poly(A)-rich RNA (a, c) and 20 pg total RNA b, d) from 
proliferating (lanes 2-4) and differentiated (lane 5 )  BC,HI cells, 
respectively, were electrophoresed on 1 % agarose gels. 
Autoradiographic exposure was 16 h (a, lanes 1 and 6; b, lanes 1 and 
6; d, lane l ) ,  5 days (a, lanes 2-5; b, lanes 2-5; c, d, lanes 2-6) 
at -70°C with an intensifying screen. The RNA probes used were 
specific for the skeletal musclc c(~, /l, a2/h  and y subunits (a-d, 
respectively). The specific activities of the four RNA probes used were 
0 . 7 - 2 . 6 ~  lo9  dpm/pg. 
and lung is consistent with the size of the cloned cDNA of the 
al subunits from heart (7036 nucleotides) [I61 and lung (7374 
nucleotides) [17], considering that both cDNA lack conven- 
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Fig 4. Models of alternate splicing events thut give rise to nucleoiide sequences of CaCh2 encoding dqferent amino-termini ( A ) ,  IS6 segments 
and tonsecutive regions ( B )  Boxes represent exons and include amino acids encoded at their 5'- and 3' ends 
tional polyadenylation signals and poly(A) tails at their 3' 
ends. Accordingly, these transcripts are thought to be derived 
from gene 2 (CaCh2). The nature of the RNA species of about 
15.5 kb in brain, heart, aorta, trachea and lung is not known. 
These less-abundant mRNA may differ in the untranslated 
sequences as a result of alternative mRNA processing, or 
represent products of different calcium channel genes. Hy- 
bridization experiments using specific probes for CaCh2A and 
CaCh2B, demonstrate that both transcripts are present in 
heart whereas only the CaCh2B transcript is expressed in 
brain, heart, aorta, trachea and lung. This tissue distribution 
suggests that the CaCh2A transcript is exclusively expressed 
in cardiac myocytes, whereas the CaCh2B transcript might be 
present in airway and vascular smooth muscle cells which are 
present in brain, heart, aorta, trachea and lung. The skeletal 
muscle differs from the other tissues since it contains a,- 
specific transcripts of 8.9 kb, although no hybridization sig- 
nals of this size were found with the CaCh2A- and CaCh2B- 
specific probes. This may be due either to the lower vascu- 
larisation of this tissue or to the presence of additional splice 
variants of the CaCh2 gene. 
Further evidence for the presence of alternate splice prod- 
ucts of the CaCh2 gene comes from PCR covering the 5' 
nucleotide sequence encoding the amino-terminus (Fig. 2 B, 
site a) and the membrane spanning region 6 of domain I 
(Fig. 2C, site b), which are different in the CaCh2A and 
CaCh2B sequences [I 71 and an insertion within the predicted 
cytoplasmic linker between domains I and I1 (Fig. 2C, site c) 
which is present in CaCh2B, but not in CaCh2A [17]. The 
amplified sequences covering site a in Fig. 2 B  are identical 
with either the CaCh2A or the CaCh2B sequence. However, 
the CaCh2A sequence is only amplified from heart, whereas 
the CaCh2B sequence is not only present in lung but also in 
trachea and heart. This tissue-specific expression of alternate 
splicing products of CaCh2 is in agreement with the results of 
the Northern-blot experiment shown in Fig. 1 b and c. In 
addition, a third splice variant was identified (clone 41) which 
is identical to CaCh2B except that it lacks 42 bp within the 
sequences that are identical in CaCh2A and Cach2B. The 
amplified sequences covering predicted transmembrane seg- 
ment 6 of domain I (Fig. 2C, site b) and the consecutive region 
(site c) are identical with the CaCh2B subtype. Fig. 4 illustrates 
models for the formation of the alternatively spliced forms of 
CaCh2 within site a, and sites b and c. Both models assume 
the existence of three alternatively spliced exons and one in- 
tervening sequence of which two exons are of the alternate 
type and the third is either used or skipped. Although this 
kind of analysis was not extended to other regions of the 
CaCh2 sequence, there is the possibility that additional alter- 
nate splice products exist. In fact, another splice variant has 
been identified in partial CaCh2-derived cDNA clones cover- 
ing the consecutive region of transmembrane segment 3 of 
domain IV [18]. The presence of regions of CaCh2 that are 
alternative splice products make it necessary to examine care- 
fully whether the cDNA segments spliced together in vitvo to 
reconstruct full-length cDNA do indeed coexist in vivo on the 
same mRNA molecule. In addition, it will be important not 
only to define which type of channel variant is expressed, but 
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also what, if any, functional correlate may be established 
bctween splice variants and type of current. The functions of 
the amino-terminus and of segment 6 of domain 1 described 
here have not been determined. However, in current topogra- 
phical models the amino-terminus is localized intracellularly 
and cytoplasmic elements have been shown to be involved in 
both activation and inactivation gating in voltage-activated 
potassium [36] and sodium channels [37]. 
cc2-specific transcripts of 8.0 kb were detected in poly(A)- 
rich RNA from each of the tissues examined. In addition, 
weakly hybridizing ccz 7.0-kb transcripts were observed. The 
size of the cloned az cDNA (about 7.8 kb including a 4.5-kb 
untranslated sequence) [lo, 161, is consistent with an 8.0-kb 
a2 mRNA, whereas the 7.0-kb az mRNA may differ in the 
3' untranslated sequence. Three P-subunit-specific transcripts 
exist in skeletal muscle, which may all differ in the coding 
and noncoding sequences as a result of alternative mRNA 
processing. The size of the 1.9-kb species is consistent with the 
size of the cloned cDNA (1835 nucleotides) [13]. Splice vari- 
ants of the same p-subunit gene appear to be present in brain 
and aorta, whereas heart contains a faintly hybridizing tran- 
script of 4.8 kb which might be derived from a second p- 
like gene. y-subunit-specific transcripts of various sizes were 
observed in skeletal muscle, brain, heart and aorta. The lack 
of 8- and 11- specific hybridization signals from lung and tra- 
chea may be due either to the lower concentration of p- and 
11-subunit mRNA in these tissues, or to the presence of sub- 
units with considerably different nucleotide sequences 
encoded by separate genes. 
Apparently splice variants of the genes for the xl ,  x2/8, p 
and 1' subunits coexist in tissues which contain L-type calcium 
channcls. The correlation of their expression with that of 
functional channels was examined in the BC3Hl cell line, 
which has been used as a model for studying muscle cell 
differentiation and the regulation of muscle-related proteins. 
Removal of growth factors from the culture medium or al- 
lowing cultures to reach confluence induces BC3H1 cells to 
differentiate and to accumulate muscle-specific gene products 
[38]. In addition, it has been shown that differentiated BC3H1 
cells express skeletal muscle voltage-activated calcium chan- 
nels [33 - 351, and partial cDNA clones isolated from BC3H1 
cells reveal a high degree of sequence similanty to the rabbit 
skeletal muscle x1 nucleotide sequence [IS]. In agreement with 
these results, the experiments shown in Fig. 3 indicate that 
BC3Hl express a skeletal-muscle-type a1 subunit and that the 
time course for induction of a skeletal-muscle-type al-,  P- and 
y-subunit mRNA is similar to that reported for the induction 
of the contractile protein mRNA and parallels the appearance 
of dihydropyridine-binding sites. Obviously, the expression of 
calcium channel x l ,  p and y subunits, but not of the az/6 
subunit, is controlled by a common regulatory mechanism in 
these cells and contributes to the formation of a dihydro- 
pyridine-sensitive calcium channel. The availability, now, of 
molecular probes for the expression of the various calcium 
channel subunits should allow further dissection of channel 
components regulating calcium channel function and modu- 
lation. 
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